Oestrogen-like effect of tamoxifen on vaginal epithelium
Abstract
30-40 mg tamoxifen were administered orally in 86 postmenopausal women with late breast malignancy who were found to be resistant to standard endocrine and chemotherapy 2 months previous to this treatment. Vaginal smears were taken before and after 30-45 days treatment. A zero pyknotic index was seen before treatment. After tamoxifen, the index regularly increased to values between 10-30% reaching 50% in 4 cases and 80% in 1. Smears became atrophic within 2 months of withdrawal of treatment. 32% of the patients responded, showing an objective tumor regression. It is unclear whether the tumor is reacting to tamoxifen as if it were an estrogen.
Read the paper
Related studies
- Multifocal clonal evolution characterized using circulating tumour DNA in a case of metastatic breast cancer
- What are the causes of late-life depression?
- Identification of SOX3 as an XX male sex reversal gene in mice and humans
- Retrospective study of concussive convulsions in elite Australian rules and rugby league footballers: phenomenology, aetiology, and outcome
- Uveal melanomas presenting during pregnancy and the investigation of oestrogen receptors in melanomas
- Metabolic and pathologic profiles of human LSS deficiency recapitulated in mice
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.